nodes	percent_of_prediction	percent_of_DWPC	metapath
Acetylcysteine—Pyruvic acid—SLC16A8—age related macular degeneration	0.14	1	CrCbGaD
Acetylcysteine—SLC7A11—Basigin interactions—SLC16A8—age related macular degeneration	0.0676	0.0786	CbGpPWpGaD
Acetylcysteine—GRIN1—Mecp2 and Associated Rett Syndrome—REST—age related macular degeneration	0.0429	0.0499	CbGpPWpGaD
Acetylcysteine—CHUK—TRAIL signaling pathway—TNFRSF10A—age related macular degeneration	0.0239	0.0278	CbGpPWpGaD
Acetylcysteine—SLC7A11—Cell surface interactions at the vascular wall—SLC16A8—age related macular degeneration	0.0225	0.0261	CbGpPWpGaD
Acetylcysteine—IKBKB—TRAIL signaling pathway—TNFRSF10A—age related macular degeneration	0.0217	0.0252	CbGpPWpGaD
Acetylcysteine—IKBKB—NF-kB is activated and signals survival—SQSTM1—age related macular degeneration	0.0214	0.0248	CbGpPWpGaD
Acetylcysteine—IKBKB—p75NTR recruits signalling complexes—SQSTM1—age related macular degeneration	0.0214	0.0248	CbGpPWpGaD
Acetylcysteine—IKBKB—p75NTR signals via NF-kB—SQSTM1—age related macular degeneration	0.0181	0.021	CbGpPWpGaD
Acetylcysteine—GRIN1—SIDS Susceptibility Pathways—REST—age related macular degeneration	0.0167	0.0194	CbGpPWpGaD
Acetylcysteine—CHUK—IL1-mediated signaling events—SQSTM1—age related macular degeneration	0.0109	0.0127	CbGpPWpGaD
Acetylcysteine—SLC7A11—SLC-mediated transmembrane transport—SLC16A8—age related macular degeneration	0.0104	0.0121	CbGpPWpGaD
Acetylcysteine—IKBKB—IL1-mediated signaling events—SQSTM1—age related macular degeneration	0.0099	0.0115	CbGpPWpGaD
Acetylcysteine—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC16A8—age related macular degeneration	0.00982	0.0114	CbGpPWpGaD
Acetylcysteine—GRIN1—SIDS Susceptibility Pathways—MAP2—age related macular degeneration	0.0096	0.0112	CbGpPWpGaD
Acetylcysteine—CHUK—Interleukin-1 signaling—SQSTM1—age related macular degeneration	0.00958	0.0111	CbGpPWpGaD
Acetylcysteine—IKBKB—Interleukin-1 signaling—SQSTM1—age related macular degeneration	0.00869	0.0101	CbGpPWpGaD
Acetylcysteine—CHUK—TNF receptor signaling pathway —SQSTM1—age related macular degeneration	0.00857	0.00996	CbGpPWpGaD
Acetylcysteine—CHUK—Endogenous TLR signaling—TLR4—age related macular degeneration	0.00836	0.00971	CbGpPWpGaD
Acetylcysteine—CHUK—IKK complex recruitment mediated by RIP1—TLR4—age related macular degeneration	0.00836	0.00971	CbGpPWpGaD
Acetylcysteine—CHUK—Cardiac Hypertrophic Response—TGFBR1—age related macular degeneration	0.00819	0.00952	CbGpPWpGaD
Acetylcysteine—SLC7A11—Hemostasis—F13B—age related macular degeneration	0.00804	0.00935	CbGpPWpGaD
Acetylcysteine—ACY1—Metabolism—NMNAT1—age related macular degeneration	0.00785	0.00913	CbGpPWpGaD
Acetylcysteine—IKBKB—TNF receptor signaling pathway —SQSTM1—age related macular degeneration	0.00777	0.00903	CbGpPWpGaD
Acetylcysteine—IKBKB—Apoptosis Modulation and Signaling—TNFRSF10A—age related macular degeneration	0.00771	0.00896	CbGpPWpGaD
Acetylcysteine—IKBKB—Endogenous TLR signaling—TLR4—age related macular degeneration	0.00758	0.00881	CbGpPWpGaD
Acetylcysteine—IKBKB—IKK complex recruitment mediated by RIP1—TLR4—age related macular degeneration	0.00758	0.00881	CbGpPWpGaD
Acetylcysteine—SLC7A11—Hemostasis—SERPING1—age related macular degeneration	0.00756	0.00879	CbGpPWpGaD
Acetylcysteine—IKBKB—Cardiac Hypertrophic Response—TGFBR1—age related macular degeneration	0.00743	0.00864	CbGpPWpGaD
Acetylcysteine—CHUK—IL-1 signaling pathway—SQSTM1—age related macular degeneration	0.00743	0.00863	CbGpPWpGaD
Acetylcysteine—CHUK—RANKL/RANK Signaling Pathway—SQSTM1—age related macular degeneration	0.00743	0.00863	CbGpPWpGaD
Acetylcysteine—SLC7A11—NRF2 pathway—SQSTM1—age related macular degeneration	0.00729	0.00848	CbGpPWpGaD
Acetylcysteine—ACY1—Metabolism—ELOVL4—age related macular degeneration	0.00686	0.00798	CbGpPWpGaD
Acetylcysteine—GRIN2D—Alzheimers Disease—APOE—age related macular degeneration	0.00679	0.00789	CbGpPWpGaD
Acetylcysteine—IKBKB—RANKL/RANK Signaling Pathway—SQSTM1—age related macular degeneration	0.00674	0.00783	CbGpPWpGaD
Acetylcysteine—IKBKB—IL-1 signaling pathway—SQSTM1—age related macular degeneration	0.00674	0.00783	CbGpPWpGaD
Acetylcysteine—SLC7A11—Hemostasis—RAD51B—age related macular degeneration	0.00656	0.00762	CbGpPWpGaD
Acetylcysteine—CHUK—Integrated Breast Cancer Pathway—RHO—age related macular degeneration	0.00651	0.00756	CbGpPWpGaD
Acetylcysteine—CHUK—p75(NTR)-mediated signaling—SQSTM1—age related macular degeneration	0.0062	0.0072	CbGpPWpGaD
Acetylcysteine—SLC7A11—Hemostasis—SLC16A8—age related macular degeneration	0.0061	0.00709	CbGpPWpGaD
Acetylcysteine—SLC7A11—Transmembrane transport of small molecules—ABCG4—age related macular degeneration	0.00592	0.00688	CbGpPWpGaD
Acetylcysteine—IKBKB—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—age related macular degeneration	0.00577	0.00671	CbGpPWpGaD
Acetylcysteine—IKBKB—p75(NTR)-mediated signaling—SQSTM1—age related macular degeneration	0.00562	0.00653	CbGpPWpGaD
Acetylcysteine—GRIN2A—Alzheimers Disease—APOE—age related macular degeneration	0.00557	0.00648	CbGpPWpGaD
Acetylcysteine—ACY1—Metabolism—SLC16A8—age related macular degeneration	0.00553	0.00643	CbGpPWpGaD
Acetylcysteine—SLC7A11—Transmembrane transport of small molecules—SLC16A8—age related macular degeneration	0.00528	0.00613	CbGpPWpGaD
Acetylcysteine—SLC7A11—Transmembrane transport of small molecules—ABCA4—age related macular degeneration	0.00528	0.00613	CbGpPWpGaD
Acetylcysteine—GRIN1—BDNF signaling pathway—SQSTM1—age related macular degeneration	0.00509	0.00591	CbGpPWpGaD
Acetylcysteine—GRIN2B—BDNF signaling pathway—SQSTM1—age related macular degeneration	0.00496	0.00576	CbGpPWpGaD
Acetylcysteine—IKBKB—p75 NTR receptor-mediated signalling—SQSTM1—age related macular degeneration	0.00489	0.00569	CbGpPWpGaD
Acetylcysteine—GRIN1—Alzheimers Disease—APOE—age related macular degeneration	0.00486	0.00565	CbGpPWpGaD
Acetylcysteine—GRIN2B—Alzheimers Disease—APOE—age related macular degeneration	0.00474	0.00551	CbGpPWpGaD
Acetylcysteine—IKBKB—GMCSF-mediated signaling events—CCL2—age related macular degeneration	0.0046	0.00534	CbGpPWpGaD
Acetylcysteine—CHUK—TWEAK Signaling Pathway—CCL2—age related macular degeneration	0.00458	0.00533	CbGpPWpGaD
Acetylcysteine—GSS—Metabolism—NMNAT1—age related macular degeneration	0.00451	0.00524	CbGpPWpGaD
Acetylcysteine—SLC22A6—SLC-mediated transmembrane transport—SLC16A8—age related macular degeneration	0.00446	0.00519	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by Interleukins—SQSTM1—age related macular degeneration	0.00433	0.00503	CbGpPWpGaD
Acetylcysteine—CHUK—Validated nuclear estrogen receptor alpha network—C3—age related macular degeneration	0.00418	0.00486	CbGpPWpGaD
Acetylcysteine—IKBKB—TWEAK Signaling Pathway—CCL2—age related macular degeneration	0.00415	0.00483	CbGpPWpGaD
Acetylcysteine—GRIN1—EPH-Ephrin signaling—KDR—age related macular degeneration	0.00414	0.00482	CbGpPWpGaD
Acetylcysteine—SLCO1B1—SLC-mediated transmembrane transport—SLC16A8—age related macular degeneration	0.00406	0.00472	CbGpPWpGaD
Acetylcysteine—GRIN2B—EPH-Ephrin signaling—KDR—age related macular degeneration	0.00404	0.0047	CbGpPWpGaD
Acetylcysteine—GSS—Metabolism—ELOVL4—age related macular degeneration	0.00394	0.00458	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling by Interleukins—SQSTM1—age related macular degeneration	0.00393	0.00456	CbGpPWpGaD
Acetylcysteine—CHUK—IL-1 signaling pathway—CCL2—age related macular degeneration	0.00369	0.00429	CbGpPWpGaD
Acetylcysteine—CHUK—Integrated Breast Cancer Pathway—TGFBR1—age related macular degeneration	0.00365	0.00425	CbGpPWpGaD
Acetylcysteine—CHUK—Regulation of toll-like receptor signaling pathway—SQSTM1—age related macular degeneration	0.00354	0.00411	CbGpPWpGaD
Acetylcysteine—GRIN1—Spinal Cord Injury—TLR4—age related macular degeneration	0.00346	0.00402	CbGpPWpGaD
Acetylcysteine—CHUK—BDNF signaling pathway—SQSTM1—age related macular degeneration	0.00344	0.004	CbGpPWpGaD
Acetylcysteine—CHUK—Integrated Pancreatic Cancer Pathway—CST3—age related macular degeneration	0.00337	0.00392	CbGpPWpGaD
Acetylcysteine—IKBKB—IL-1 signaling pathway—CCL2—age related macular degeneration	0.00335	0.00389	CbGpPWpGaD
Acetylcysteine—CHUK—MyD88:Mal cascade initiated on plasma membrane—CD36—age related macular degeneration	0.00324	0.00377	CbGpPWpGaD
Acetylcysteine—IKBKB—Regulation of toll-like receptor signaling pathway—SQSTM1—age related macular degeneration	0.00321	0.00373	CbGpPWpGaD
Acetylcysteine—GSS—Metabolism—SLC16A8—age related macular degeneration	0.00318	0.00369	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—C9—age related macular degeneration	0.00317	0.00369	CbGpPWpGaD
Acetylcysteine—IKBKB—BDNF signaling pathway—SQSTM1—age related macular degeneration	0.00312	0.00363	CbGpPWpGaD
Acetylcysteine—IKBKB—MAPK Signaling Pathway—TGFBR1—age related macular degeneration	0.00304	0.00353	CbGpPWpGaD
Acetylcysteine—CHUK—Integrated Pancreatic Cancer Pathway—TGFBR1—age related macular degeneration	0.00303	0.00352	CbGpPWpGaD
Acetylcysteine—GRIN1—Spinal Cord Injury—CCL2—age related macular degeneration	0.00296	0.00345	CbGpPWpGaD
Acetylcysteine—IKBKB—MyD88:Mal cascade initiated on plasma membrane—CD36—age related macular degeneration	0.00294	0.00342	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—C9—age related macular degeneration	0.00288	0.00335	CbGpPWpGaD
Acetylcysteine—ACY1—Metabolism—LIPC—age related macular degeneration	0.00283	0.00329	CbGpPWpGaD
Acetylcysteine—CHUK—MyD88:Mal cascade initiated on plasma membrane—TLR4—age related macular degeneration	0.0028	0.00326	CbGpPWpGaD
Acetylcysteine—CHUK—Activated TLR4 signalling—CD36—age related macular degeneration	0.0028	0.00325	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—CFI—age related macular degeneration	0.00275	0.0032	CbGpPWpGaD
Acetylcysteine—ACY1—Metabolism—CETP—age related macular degeneration	0.00273	0.00318	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism of lipids and lipoproteins—ELOVL4—age related macular degeneration	0.00269	0.00313	CbGpPWpGaD
Acetylcysteine—CHUK—MyD88-independent cascade—TLR4—age related macular degeneration	0.00269	0.00313	CbGpPWpGaD
Acetylcysteine—CHUK—Toll Like Receptor 4 (TLR4) Cascade—CD36—age related macular degeneration	0.00263	0.00306	CbGpPWpGaD
Acetylcysteine—CHUK—Toll-like Receptor Signaling Pathway—TLR4—age related macular degeneration	0.00263	0.00305	CbGpPWpGaD
Acetylcysteine—SLC7A11—Transmembrane transport of small molecules—CETP—age related macular degeneration	0.00261	0.00303	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—CFHR3—age related macular degeneration	0.00256	0.00297	CbGpPWpGaD
Acetylcysteine—SLC22A6—Transmembrane transport of small molecules—ABCG4—age related macular degeneration	0.00255	0.00296	CbGpPWpGaD
Acetylcysteine—IKBKB—MyD88:Mal cascade initiated on plasma membrane—TLR4—age related macular degeneration	0.00254	0.00295	CbGpPWpGaD
Acetylcysteine—IKBKB—Activated TLR4 signalling—CD36—age related macular degeneration	0.00254	0.00295	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—CFI—age related macular degeneration	0.0025	0.0029	CbGpPWpGaD
Acetylcysteine—CHUK—TNF alpha Signaling Pathway—CCL2—age related macular degeneration	0.00245	0.00284	CbGpPWpGaD
Acetylcysteine—IKBKB—MyD88-independent cascade—TLR4—age related macular degeneration	0.00244	0.00283	CbGpPWpGaD
Acetylcysteine—CHUK—Activated TLR4 signalling—TLR4—age related macular degeneration	0.00242	0.00281	CbGpPWpGaD
Acetylcysteine—IKBKB—Toll Like Receptor 4 (TLR4) Cascade—CD36—age related macular degeneration	0.00239	0.00278	CbGpPWpGaD
Acetylcysteine—IKBKB—Toll-like Receptor Signaling Pathway—TLR4—age related macular degeneration	0.00238	0.00277	CbGpPWpGaD
Acetylcysteine—CHUK—Toll-Like Receptors Cascades—CD36—age related macular degeneration	0.00234	0.00273	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—CFHR3—age related macular degeneration	0.00232	0.0027	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Transmembrane transport of small molecules—ABCG4—age related macular degeneration	0.00232	0.00269	CbGpPWpGaD
Acetylcysteine—GRIN1—EPH-Ephrin signaling—VEGFA—age related macular degeneration	0.00228	0.00265	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—C2—age related macular degeneration	0.00228	0.00265	CbGpPWpGaD
Acetylcysteine—CHUK—Toll Like Receptor 4 (TLR4) Cascade—TLR4—age related macular degeneration	0.00228	0.00265	CbGpPWpGaD
Acetylcysteine—SLC22A6—Transmembrane transport of small molecules—ABCA4—age related macular degeneration	0.00227	0.00264	CbGpPWpGaD
Acetylcysteine—SLC22A6—Transmembrane transport of small molecules—SLC16A8—age related macular degeneration	0.00227	0.00264	CbGpPWpGaD
Acetylcysteine—GRIN2B—EPH-Ephrin signaling—VEGFA—age related macular degeneration	0.00223	0.00259	CbGpPWpGaD
Acetylcysteine—IKBKB—TNF alpha Signaling Pathway—CCL2—age related macular degeneration	0.00222	0.00258	CbGpPWpGaD
Acetylcysteine—IKBKB—Activated TLR4 signalling—TLR4—age related macular degeneration	0.00219	0.00255	CbGpPWpGaD
Acetylcysteine—IKBKB—Toll-Like Receptors Cascades—CD36—age related macular degeneration	0.00213	0.00247	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—C2—age related macular degeneration	0.00207	0.0024	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Transmembrane transport of small molecules—ABCA4—age related macular degeneration	0.00206	0.0024	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Transmembrane transport of small molecules—SLC16A8—age related macular degeneration	0.00206	0.0024	CbGpPWpGaD
Acetylcysteine—IKBKB—Toll Like Receptor 4 (TLR4) Cascade—TLR4—age related macular degeneration	0.00206	0.0024	CbGpPWpGaD
Acetylcysteine—CHUK—Regulation of toll-like receptor signaling pathway—TLR4—age related macular degeneration	0.00205	0.00238	CbGpPWpGaD
Acetylcysteine—CHUK—Toll-Like Receptors Cascades—TLR4—age related macular degeneration	0.00203	0.00236	CbGpPWpGaD
Acetylcysteine—CHUK—Cytokine Signaling in Immune system—SQSTM1—age related macular degeneration	0.00202	0.00235	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by NGF—SQSTM1—age related macular degeneration	0.00199	0.00231	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—NMNAT1—age related macular degeneration	0.00195	0.00227	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—RDH8—age related macular degeneration	0.00195	0.00227	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—CFH—age related macular degeneration	0.00191	0.00222	CbGpPWpGaD
Acetylcysteine—IKBKB—Regulation of toll-like receptor signaling pathway—TLR4—age related macular degeneration	0.00186	0.00216	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—CFB—age related macular degeneration	0.00185	0.00215	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—C9—age related macular degeneration	0.00185	0.00215	CbGpPWpGaD
Acetylcysteine—IKBKB—Toll-Like Receptors Cascades—TLR4—age related macular degeneration	0.00184	0.00214	CbGpPWpGaD
Acetylcysteine—IKBKB—Cytokine Signaling in Immune system—SQSTM1—age related macular degeneration	0.00183	0.00213	CbGpPWpGaD
Acetylcysteine—SLC7A11—Hemostasis—CD36—age related macular degeneration	0.00181	0.0021	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling by NGF—SQSTM1—age related macular degeneration	0.0018	0.00209	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—CFH—age related macular degeneration	0.00173	0.00201	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—RPE65—age related macular degeneration	0.00171	0.00198	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—CFB—age related macular degeneration	0.00168	0.00195	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—C9—age related macular degeneration	0.00168	0.00195	CbGpPWpGaD
Acetylcysteine—ACY1—Metabolism—CD36—age related macular degeneration	0.00164	0.00191	CbGpPWpGaD
Acetylcysteine—GSS—Metabolism—LIPC—age related macular degeneration	0.00163	0.00189	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—CFI—age related macular degeneration	0.0016	0.00186	CbGpPWpGaD
Acetylcysteine—GSS—Metabolism—CETP—age related macular degeneration	0.00157	0.00182	CbGpPWpGaD
Acetylcysteine—GRIN1—Axon guidance—KDR—age related macular degeneration	0.00154	0.00179	CbGpPWpGaD
Acetylcysteine—GRIN1—SIDS Susceptibility Pathways—VEGFA—age related macular degeneration	0.00152	0.00177	CbGpPWpGaD
Acetylcysteine—GRIN2B—Axon guidance—KDR—age related macular degeneration	0.0015	0.00175	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—CFHR3—age related macular degeneration	0.00149	0.00173	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—CFI—age related macular degeneration	0.00145	0.00169	CbGpPWpGaD
Acetylcysteine—ACY1—Metabolism—APOE—age related macular degeneration	0.00145	0.00168	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—ABCA4—age related macular degeneration	0.00138	0.0016	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—NMNAT1—age related macular degeneration	0.00137	0.00159	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—RDH8—age related macular degeneration	0.00137	0.00159	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—CFHR3—age related macular degeneration	0.00135	0.00157	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—C2—age related macular degeneration	0.00133	0.00154	CbGpPWpGaD
Acetylcysteine—GRIN1—Developmental Biology—CD36—age related macular degeneration	0.00127	0.00148	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—RDH8—age related macular degeneration	0.00124	0.00144	CbGpPWpGaD
Acetylcysteine—GRIN2B—Developmental Biology—CD36—age related macular degeneration	0.00124	0.00144	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—C2—age related macular degeneration	0.0012	0.0014	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—ELOVL4—age related macular degeneration	0.0012	0.00139	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—RHO—age related macular degeneration	0.0012	0.00139	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—RPE65—age related macular degeneration	0.0012	0.00139	CbGpPWpGaD
Acetylcysteine—SLC22A6—Transmembrane transport of small molecules—CETP—age related macular degeneration	0.00112	0.0013	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—CFH—age related macular degeneration	0.00111	0.00129	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism of lipids and lipoproteins—LIPC—age related macular degeneration	0.00111	0.00129	CbGpPWpGaD
Acetylcysteine—GRIN1—Developmental Biology—KDR—age related macular degeneration	0.0011	0.00128	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—RPE65—age related macular degeneration	0.00108	0.00126	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—CFB—age related macular degeneration	0.00108	0.00125	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism of lipids and lipoproteins—CETP—age related macular degeneration	0.00107	0.00125	CbGpPWpGaD
Acetylcysteine—GRIN2B—Developmental Biology—KDR—age related macular degeneration	0.00107	0.00125	CbGpPWpGaD
Acetylcysteine—CHUK—Integrated Breast Cancer Pathway—VEGFA—age related macular degeneration	0.00106	0.00123	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Transmembrane transport of small molecules—CETP—age related macular degeneration	0.00102	0.00118	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—CFH—age related macular degeneration	0.00101	0.00117	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—CFB—age related macular degeneration	0.000977	0.00114	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—SLC16A8—age related macular degeneration	0.000967	0.00112	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—ABCA4—age related macular degeneration	0.000964	0.00112	CbGpPWpGaD
Acetylcysteine—GSS—Metabolism—CD36—age related macular degeneration	0.000943	0.0011	CbGpPWpGaD
Acetylcysteine—CHUK—Integrated Pancreatic Cancer Pathway—VEGFA—age related macular degeneration	0.000876	0.00102	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—ABCA4—age related macular degeneration	0.000874	0.00102	CbGpPWpGaD
Acetylcysteine—SLC7A11—Hemostasis—VEGFA—age related macular degeneration	0.000861	0.001	CbGpPWpGaD
Acetylcysteine—GRIN1—Axon guidance—VEGFA—age related macular degeneration	0.000848	0.000986	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—RHO—age related macular degeneration	0.000838	0.000974	CbGpPWpGaD
Acetylcysteine—GSS—Metabolism—APOE—age related macular degeneration	0.000832	0.000967	CbGpPWpGaD
Acetylcysteine—GRIN2B—Axon guidance—VEGFA—age related macular degeneration	0.000827	0.000961	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—RHO—age related macular degeneration	0.00076	0.000884	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—CD36—age related macular degeneration	0.00076	0.000883	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—CST3—age related macular degeneration	0.000748	0.00087	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—CD36—age related macular degeneration	0.000729	0.000848	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—C3—age related macular degeneration	0.00072	0.000837	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—C3—age related macular degeneration	0.000691	0.000803	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—CD36—age related macular degeneration	0.000689	0.000801	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—CRP—age related macular degeneration	0.000685	0.000796	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—TGFBR1—age related macular degeneration	0.000672	0.000781	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—CD36—age related macular degeneration	0.000661	0.000769	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—SQSTM1—age related macular degeneration	0.00066	0.000767	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—TLR4—age related macular degeneration	0.000656	0.000763	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—C3—age related macular degeneration	0.000653	0.000759	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	0.000644	0.000749	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—C3—age related macular degeneration	0.000627	0.000729	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—CRP—age related macular degeneration	0.000621	0.000722	CbGpPWpGaD
Acetylcysteine—GRIN1—Developmental Biology—VEGFA—age related macular degeneration	0.000605	0.000704	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—SQSTM1—age related macular degeneration	0.000598	0.000696	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—TLR4—age related macular degeneration	0.000595	0.000692	CbGpPWpGaD
Acetylcysteine—GRIN2B—Developmental Biology—VEGFA—age related macular degeneration	0.00059	0.000686	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	0.000568	0.000661	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—LIPC—age related macular degeneration	0.000495	0.000575	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—CETP—age related macular degeneration	0.000477	0.000555	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—TGFBR1—age related macular degeneration	0.000471	0.000547	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—CD36—age related macular degeneration	0.000442	0.000514	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—TGFBR1—age related macular degeneration	0.000427	0.000496	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—SQSTM1—age related macular degeneration	0.000427	0.000496	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—C3—age related macular degeneration	0.000419	0.000487	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—CD36—age related macular degeneration	0.000401	0.000466	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—CRP—age related macular degeneration	0.000399	0.000464	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—SQSTM1—age related macular degeneration	0.000387	0.00045	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—TLR4—age related macular degeneration	0.000382	0.000444	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—C3—age related macular degeneration	0.00038	0.000442	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—CRP—age related macular degeneration	0.000362	0.00042	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—APOE—age related macular degeneration	0.00036	0.000419	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—TLR4—age related macular degeneration	0.000347	0.000403	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—CD36—age related macular degeneration	0.000287	0.000334	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—C3—age related macular degeneration	0.000271	0.000315	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—APOE—age related macular degeneration	0.000253	0.000294	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—APOE—age related macular degeneration	0.000252	0.000293	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—KDR—age related macular degeneration	0.000247	0.000287	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—C3—age related macular degeneration	0.000246	0.000286	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—APOE—age related macular degeneration	0.000229	0.000266	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—KDR—age related macular degeneration	0.000224	0.000261	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—CCL2—age related macular degeneration	0.000212	0.000247	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—CCL2—age related macular degeneration	0.000192	0.000224	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—VEGFA—age related macular degeneration	0.000136	0.000158	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—VEGFA—age related macular degeneration	0.000123	0.000144	CbGpPWpGaD
